Table 1. Demographic, Clinical and Laboratory Characteristics of the Studied Patients.
| Characteristics | HBV (n = 12) | HCV (n = 29) | Bilharziasis (n = 9) | P-value | |
|---|---|---|---|---|---|
| Age (years) | Patients | 10.75 ± 1.04 | 11.54 ± 0.63 | 11.89 ± 1.1 | 0.206 |
| Controls 10.5 ± 0.46 | |||||
| Male n (%) | Patients | 10 (83.3%) | 22 (75.9%) | 9 (100%) | 0.355 |
| Controls 22 (73.3%) | |||||
| Hematemesis n (%) | 1 (8.3%) | 4 (13.8%) | 3 (33.3%) | 0.267 | |
| Epistaxis n (%) | 1 (8.3%) | 4 (13.8%) | 2 (22.2%) | 0.662 | |
| Hepatomegaly n (%) | 2 (16.6%) | 8 (27.6%) | 2 (22.2%) | 0.751 | |
| Splenomegaly n (%) | 7 (58.3%) | 19 (56.5%) | 8 (88.8%) | 0.301 | |
| Ascites n (%) | 2 (16.6%) | 4 (13.8%) | 3 (33.3%) | 0.506 | |
| Hb (g/dl) | 10.5 ± 0.42 | 10.89 ± 0.34 | 11.18 ± 0.39 | 0.659 | |
| WBCs (x 103/mm3) | 6.38 ± 0.95 | 7.2 ± 0.49 | 7.04 ± 0.67 | 0.624 | |
| Platelets (x 103/mm3) | 135.4 ± 17.3 | 161.9 ± 14.1 | 196.7 ± 17.03 | 0.64 | |
| TB (mg/dl) | 1.83 ± 0.22 | 1.32 ± 0.14 | 0.95 ± 0.16 | 0.026* | |
| ALT (U/L) | 72.58 ± 12.41 | 107.37 ± 28.1 | 30.67 ± 3.21 | 0.03* | |
| AST (U/L) | 71.17 ± 10.76 | 120.07 ± 21.78 | 38.56 ± 6.09 | 0.002** | |
| Albumin (g/dl) | 3.49 ± 0.19 | 3.57 ± 0.11 | 3.8 ± 0.1 | 0.35 | |
| Alkaline phosphatase (U/L) | 214.33 ± 41.18 | 165.19 ± 28.86 | 80.33 ± 12.42 | 0.02* | |
| GGT (U/L) | 54.33 ± 15.98 | 59.87 ± 11.06 | 38.78 ± 9.64 | 0.61 | |
| PC (%) | 69.42 ± 6.03 | 65.61 ± 2.46 | 75.67 ± 4.1 | 0.163 | |
Quantitative data are expressed as mean ± SEM and qualitative data as number and %. Significance was tested using non-parametric Kruskal-Wallis test or Chi-square test. *P ≤ 0.05, **P ≤ 0.01